The ROIC trajectory — swinging between 4.6% (2025Q4) and 10.0% (2024Q3) with no clear upward trend — suggests the core industrial engine is not compounding returns meaningfully, which is consistent with the near-flat revenue line and the asset base shrinking roughly 9% while leverage holds steady. ROIC of 8.4% likely sits below 3M's implied weighted average cost of capital, indicating that on an invested-capital basis the post-Solventum entity may be destroying value rather than creating it, even as the headline ROE flatters. The widening ROE-ROIC divergence is, in our reading, a warning that traditional return-on-equity frameworks will mislead anyone modeling 3M's earning power from the equity account.

Gross margin's parallel swing from 33.6% to 42.3% with an essentially static top line points to non-recurring cost absorption or product-mix effects rather than a structural improvement in the franchise; investors should treat the 23.7% operating margin as an upper bound of normalized earning power until multi-quarter stability is demonstrated. Net margin of 20.9% in 2026Q3, against a ten-quarter range of 9.4% to 21.8%, likewise looks more like an outlier print than a trend, particularly given the weak 0.35 operating-cash-flow-to-net-income conversion recorded in the same quarter. Adjusted for settlement timing and the Solventum discontinuity, the more defensible read is a mid-teens net margin business with genuine but not peer-leading pricing power, evidenced by the 42.3% gross margin trailing Illinois Tool Works' reported 44.1%.

The debt-to-equity print is mechanically amplified by the shrunken $4.1B equity base, so the more informative gauge is debt-to-EBITDA, which remains elevated at 7.92x in 2026Q3 versus Honeywell's 2.24x debt-to-equity profile, implying materially less refinancing headroom than the peer group enjoys. Notably, interest coverage has not been disclosed in the two most recent quarters, so the trajectory of debt-service comfort cannot be confirmed from current data — an item we would flag for further investigation rather than infer. With single-digit organic growth and multi-billion-dollar legal outflows scheduled over the coming decade, the combination suggests deleveraging will be slow and largely dependent on asset sales or working-capital release rather than earnings growth.

The gap between trailing and forward multiples embeds an implicit expectation that 2026Q3's 20.9% net margin represents run-rate earnings — an assumption that looks aggressive given the ten-quarter FCF margin range of -32.3% to 25.4% and cumulative free cash flow of only about $2.9B against $13.4B of dividends and buybacks over the same window. At 17.86x EV/EBITDA, 3M sits between Honeywell's 11.59x and ITW's 18.98x, which may indicate the market is unwilling to assign either a full conglomerate multiple or a distressed discount while PFAS and combat-earplug outflows remain unresolved. Relative to its own history the forward EV/EBITDA of 11.59x looks undemanding only if one accepts management's implied earnings recovery; we would anchor instead on EV/EBITDA adjusted for recurring settlement cash costs, which likely sits above the headline.